Display options
Cite
Feehally J, Barratt J. The Genetics of IgA Nephropathy: An Overview from Western Countries. Kidney Dis (Basel). 2015;1(1):33-41doi: 10.1159/000381738.
Feehally, J., & Barratt, J. (2015). The Genetics of IgA Nephropathy: An Overview from Western Countries. Kidney diseases (Basel, Switzerland), 1(1), 33-41. https://doi.org/10.1159/000381738
Feehally, John, and Barratt, Jonathan. "The Genetics of IgA Nephropathy: An Overview from Western Countries." Kidney diseases (Basel, Switzerland) vol. 1,1 (2015): 33-41. doi: https://doi.org/10.1159/000381738
Feehally J, Barratt J. The Genetics of IgA Nephropathy: An Overview from Western Countries. Kidney Dis (Basel). 2015 May;1(1):33-41. doi: 10.1159/000381738. Epub 2015 Apr 23. PMID: 27536663; PMCID: PMC4934805.
Copy Download .nbib Format: NLM
Share it on

Kidney Dis (Basel). 2015 May;1(1):33-41. doi: 10.1159/000381738. Epub 2015 Apr 23.

The Genetics of IgA Nephropathy: An Overview from Western Countries.

Kidney diseases (Basel, Switzerland)

John Feehally, Jonathan Barratt

Affiliations

  1. The John Walls Renal Unit, University Hospitals of Leicester, and Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.

PMID: 27536663 PMCID: PMC4934805 DOI: 10.1159/000381738

Abstract

BACKGROUND: IgA nephropathy (IgAN) is the commonest primary glomerulonephritis worldwide and a significant cause of chronic kidney disease and end-stage renal disease. It is widely accepted that genetic factors play a role in the pathogenesis of IgAN. However, the identity of these genetic factors remains uncertain.

SUMMARY: Critical to all genetic studies is a precise phenotypic definition of the disease. It is well recognised that IgAN displays striking phenotypic variation, raising the possibility that it may not be a single disease and it may not be the same disease in different parts of the world. In this review, we discuss the challenges that this phenotypic variation poses to interpreting genetic data and the current evidence for specific gene involvement in IgAN, focusing particularly on data from European IgAN cohorts.

KEY MESSAGE: With advances in genetic techniques, in particular next-generation sequencing, and an increased understanding of the importance of copy number variations, epigenetics and transcriptomics, it is likely that we will gain a greater understanding of the genetic basis for IgAN. However, due to the lack of consistency in epidemiological clinicopathological studies both within and between continents, this will only be achieved if we are able to more precisely phenotype IgAN populations.

FACTS FROM EAST AND WEST: The reported prevalence of IgAN is higher in Asia than in Europe and North America. However, differences in use of biopsy for the diagnosis of IgAN should be taken into account in analysing data from both East and West. In Europe, IgAN affects men more frequently than women; this is not the case in Asia. Familial IgAN has been more frequently reported in Europe than in Asia. Within Europe, familial IgAN is more evident in southern than in northern populations. Changes in the pattern of serum IgA1 O-glycosylation is a common finding in IgAN patients in the East and West. SNPs within the gene coding for the enzyme C1GALT1 have been reported in Chinese and European patients. However, there is no evidence for a role of gene polymorphism of the C1GALT1 chaperone cosmc in Europeans. Genetic variants in the HLA gene family have been observed in populations from the East and West. Associations between IgAN and variants of the TAP1/PSMB and DEFA genes were observed in Asian but not in Western patients. Association with the angiotensin-converting enzyme gene was seen only in Asian patients.

Keywords: Candidate genes; Genome-wide association study; HLA; IgA nephropathy; Single nucleotide polymorphisms

References

  1. Kidney Int. 2000 May;57(5):1818-35 - PubMed
  2. Nature. 2006 Feb 16;439(7078):851-5 - PubMed
  3. Nephrol Dial Transplant. 2007 Mar;22(3):772-7 - PubMed
  4. Nat Rev Nephrol. 2014 May;10(5):249-56 - PubMed
  5. Clin Exp Immunol. 1993 Apr;92(1):139-44 - PubMed
  6. Kidney Int. 2011 Jan;79(1):23-32 - PubMed
  7. Nephrol Dial Transplant. 2013 Dec;28(12):2946-60 - PubMed
  8. Clin Exp Immunol. 1995 Jun;100(3):470-4 - PubMed
  9. Biochim Biophys Acta. 2014 Oct;1842(10):1903-1909 - PubMed
  10. Clin J Am Soc Nephrol. 2010 Nov;5(11):2069-74 - PubMed
  11. Kidney Int. 2007 Mar;71(5):448-53 - PubMed
  12. PLoS Genet. 2012;8(6):e1002765 - PubMed
  13. Semin Nephrol. 1987 Dec;7(4):277-9 - PubMed
  14. J Am Soc Nephrol. 2002 Feb;13(2):453-60 - PubMed
  15. Science. 2004 Jul 23;305(5683):525-8 - PubMed
  16. J Am Soc Nephrol. 2012 May;23(5):814-24 - PubMed
  17. Clin Nephrol. 2008 Nov;70(5):377-84 - PubMed
  18. Nephrol Dial Transplant. 2009 Jan;24(1):321-4 - PubMed
  19. J Am Soc Nephrol. 2006 Jun;17(6):1724-34 - PubMed
  20. Nephrol Dial Transplant. 1996 Mar;11(3):558-9 - PubMed
  21. Eur J Hum Genet. 2015 Jul;23(7):940-8 - PubMed
  22. Nephrol Dial Transplant. 2009 May;24(5):1524-8 - PubMed
  23. J Am Soc Nephrol. 2010 Oct;21(10 ):1791-7 - PubMed
  24. J Am Soc Nephrol. 2012 Oct;23(10):1753-60 - PubMed
  25. Nat Genet. 2011 Mar 13;43(4):321-7 - PubMed
  26. Kidney Int. 2003 Jun;63(6):2286-94 - PubMed
  27. Am J Hum Genet. 2006 Dec;79(6):1130-4 - PubMed
  28. J Am Soc Nephrol. 2007 Aug;18(8):2408-15 - PubMed
  29. Nat Genet. 2014 Nov;46(11):1187-96 - PubMed
  30. Curr Opin Genet Dev. 2003 Dec;13(6):569-75 - PubMed
  31. Nat Genet. 2000 Nov;26(3):354-7 - PubMed
  32. J Urol Nephrol (Paris). 1968 Sep;74(9):694-5 - PubMed
  33. Nephrol Dial Transplant. 1989;4(11):943-6 - PubMed
  34. Nat Genet. 2011 Dec 25;44(2):178-82 - PubMed
  35. Kidney Int. 2012 May;81(9):833-43 - PubMed

Publication Types